2023 International Congress » Parkinson's Disease: Neuroimaging

3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET striatal binding patterns in patients with Parkinson’s Disease and Parkinson Plus Syndromes.

A. Buckland, T. Lee, R. Stell, S. Ghosh, J. Rodrigues, W. Yau, S. Vijayan, R. Francis, K. Sek, L. Morandeau, A. Jacques, T. Hagan, J. Watts, E. Campbell, N. Loh (Nedlands, Australia)

A 20-Year Follow-Up Case Report with Three DaT-SPECT Scans in Parkinson’s Disease Diagnosis

S. Virameteekul, K. Bhatia (London, United Kingdom)

Accelerated longitudinal brain atrophy in the ‘diffuse malignant’ Parkinson’s disease subtype

SM. Fereshtehnejad, R. Moqadam, R. Postuma, M. Dadar, Y. Zeighami (Ottawa, Canada)

Agreement between swallow tail sign asymmetry and clinical laterality in Parkinson’s disease

M. Rohonczi, G. Perlaki, G. Hernádi, N. Kovács (Pécs, Hungary)

Alterations of the Right Olfactory Orbitofrontal Cortex and olfactory impairment in Parkinson’s Disease

L. Pesantez Pacheco, M. Saquib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

Altered brain energetics in Parkinson’s Disease: a multimodal neuroimaging study

C. Bevington, J-C. Cheng, R. Jayde-Williams, B. Pike, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease

L. Morris, S. Harrison, T. Melzer, J. Dalrymple-Alford, T. Anderson, M. Macaskill, C. Le Heron (Christchurch, New Zealand)

An in-vivo study of the integrity of the nigrostriatal pathways in drug-naive Parkinson’s disease patients using [11C]PE2I PET and neuromelanin-Magnetic Resonance Imaging

G. Pagano, H. Wilson, E. de Natale, F. Niccolini, S. Polychronis, T. Yousaf, R. Gunn, E. Rabiner, M. Mehta, M. Politis (Basel, Switzerland)

An Interesting Case of COVID-19 related Parkinsonism

P. Bhatia, A. Ata, K. Bailey (Tampa, USA)

An investigation of early changes in the brain due to mild cognitive impairment in Parkinson’s disease

N. Saadat, E. Mazerolle, J. Gawryluk (Victoria, Canada)

Application of multi-parametric diffusion MRI in detecting visual disturbances in advanced Parkinson’s disease population

K. Shivok, I. Ailes, M. Syed, I. Shelley, A. Alhussein, I. Fayed, T-W. Liang, C. Wu, A. Sharan, F. Mohamed, R. Sergott, L. Krisa, M. Alizadeh (Philadelphia, USA)

Artificial intelligence for the improvement of imaging biomarkers in Parkinson’s disease

V. Dzialas, E. Doering, K. Simonyan, A. Strafella, D. Vaillancourt, T. van Eimeren (Cologne, Germany)

Assessing Gait Disturbances in Parkinson’s Disease Using Multi-Spectral Diffusion Weighted Imaging

I. Shelley, I. Ailes, M. Syed, K. Shivok, J. Miao, L. Krisa, F. Mohamed, R. Sergott, T. Liang, A. Sharan, M. Kogan, C. Wu, M. Alizadeh, O. Shoraka (Philadelphia, USA)

Assessing the swallow tail sign in clinical practice

MA. Ruiz Yanzi, E. Natera-Villalba, JA. Pineda-Pardo, M. Matarazzo (Madrid, Spain)

Association Between Anticholinergic Burden, MCI, and Cholinergic Denervation

R. Paalanen, S. Roytman, P. Kanel, N. Bohnen (Ann Arbor, USA)

Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

Association of Increased Frontal White Matter A2A Receptor Availability with Decreased Frontal Gray Matter Volume in Patients with Parkinson’s Disease

I. Waggan, E. Rissanen, J. Tuisku, M. Matilainen, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

Asymmetric synaptic density and glucose consumption in subjects with non-demented Parkinson’s Disease, as measured with [11C]UCB-J and [18F]FDG PET.

K. Andersen, A. Hansen, J. Horsager, K. Knudsen, P. Borghammer (Aarhus, Denmark)

Automated parcellation of the cerebellum in patients with newly diagnosed Parkinson’s disease

B. Facer, C. de Bezenac, A. Macerollo, T. Butts, R. Sadavarte, J. Farah, S. Keller (Liverpool, United Kingdom)

Automated VMAT2 [18F]AV-133 PET analysis in Parkinson’s disease

R. Manber, B. Brito Vega, C. Mcginnity (London, United Kingdom)

Basal ganglia shape in de novo Parkinson’s disease patients can predict the onset of Levodopa Induced Dyskinesias

S. Shukla, M. Patnaik, A. Kumar, N. Thirugnanasambandam, S. Tinaz (Mumbai, India)

Brain first-body first: is the dat-scan useful?

G. Bellini, G. Palermo, D. Frosini, E. Benevento, E. Del Prete, M G. Tedeschi, S. Visinoni, A. Francesconi, R. Ceravolo (Pisa, Italy)

Brain MRI volumetry analysis for patients with Parkinson’s disease suffering from REM sleep behavior disorder: a pilot study

T. Vanagas, G. Paulekiene, A. Radziunas, R. Balnyte, E. Pajediene, E. Paulekas (Kaunas, Lithuania)

Cerebral Topography of [11C]-Flumazenil GABAA Receptor Expression in Parkinson’s Disease Fallers and Freezers

N. Bohnen, S. Roytman, J. Barr, K. Frey, P. Scott, R. Koeppe, P. Kanel (Ann Arbor, USA)

Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)

Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

Clinical and functional determinants of motor reserve in patients with de novo Parkinson’s disease

S. Prange, M. Hoenig, H. Theis, E. Metereau, S. Thobois, T. van Eimeren (Cologne, Germany)

Clinical and radiological factors associated with mortality in Parkinson’s disease

G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, R. Luquin (Pamplona, Spain)

Clinical and radiological gender differences in Parkinson’s disease

G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, M. Riverol, S. Meles, KL. Leenders, P. Tomse, M. Perovnik, M. Trost, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)

Combined approach in the diagnostic of Parkinson’s disease

D D. Pokhabov, V. Abramov, T. Subbotina, D V. Pokhabov (Krasnoyarsk, Russian Federation)

Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)

Comparison of the MIBG uptake in the major salivary glands between progressive supranuclear palsy/corticobasal syndrome and Parkinson’s disease

J. Ebina, M. Shibukawa, H. Morioka, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, S. Mizumura, S. Orimo, O. Kano (Tokyo, Japan)

Connectivity Profile for Deep Brain Stimulation in Early-Stage Parkinson’s Disease

M. Hacker, N. Rajamani, C. Neudorfer, B. Hollunder, S. Oxenford, N. Li, A. Sternberg, T. Davis, P. Konrad, A. Horn, D. Charles (Nashville, USA)

Correlation between Striatal degeneration and Cerebellar fiber alterations of Parkinson’s disease

A. Shindo, T. Ogawa, T. Hatano, S. Ueno, W. Sako, K. Kamagata, A. Christina, H. Amano-Takeshige, W. Uchida, G. Oyama, A. Umemura, H. Iwamuro, M. Ito, A. Nakanishi, K. Murakami, S. Aoki, N. Hattori (Bunkyo-ku, Tokyo, Japan)

Cortical mean diffusivity changes in Parkinson’s disease with probable RBD

J. Pardo, V. Montal, A. Campabadal, J. Oltra, C. Uribe, I. Roura, MJ. Martí, Y. Compta, A. Iranzo, J. Fortea, C. Junqué, B. Segura (Barcelona, Spain)

Cortical thickness and global atrophy progression in Parkinson’s disease with probable RBD

J. Oltra, A. Campabadal, C. Uribe, J. Pardo, I. Roura, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

Deep brain stimulation impacts functional brain connectivity in Parkinson’s disease.

R. Jech, F. Ruzicka, D. Kiakou, A. Lasica, P. Filip, K. Burdova, D. Urgosik, K. Mueller (Prague, Czech Republic)

Detection of Camptocormia Using Ultrasound in Parkinson’s Disease

R. Yilmaz, R. Wolke, N. Puls, M. Sorgun, G. Deuschl, D. Berg, N. Margraf (Ankara, Turkey)

Diabetes impact on nigrostriatal vulnerability in Parkinson’s Disease

A. Galli, A. Pilotto, C. Zatti, C. Tirloni, A. Lupini, B. Paghera, A. Padovani (Brescia, Italy)

Diagnosis of Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy with 7T-MRI substantia nigra imaging

D. Su, Z. Zhang, Z. Zhang, T. Wu, J. Jing, T. Feng (Beijing, China)

Diffusion imaging study of mild behavioral impairment in Parkinson’s disease.

H. Almgren, M. Descoteaux, M. Ghahremani, Z. Ismail, O. Monchi (Calgary, Canada)

Disruption of Locus Coeruleus-Related Functional Networks in Parkinson’s Disease

J. Sun, J. Ma, L. Gao, J. Wang, D. Zhang, L. Chen, J. Fang, T. Feng, T. Wu (Beijing, China)

Distinct deep grey matter iron accumulation in tremoric syndromes; an apparent quantitative susceptibility mapping mangetic resonance study

A. Martín-Bastida, I. Aviles-Olmos, A. Gorospe-Osinalde, V. Suarez-Vega, P. Dominguez-Echavarri, R. García-Eulate, C. Sánchez-Catasús, MC. Rodríguez-Oroz (Pamplona, Spain)

Does hyposmia induce apathy in early Parkinson’s disease? Lessons from structural brain connectivity

A. Martinez-Nunez, H. Soltanian-Zadeh, K. Latack, N. Ghazi, A. Mahajan (Detroit, USA)

Dopamine depletion of striatal subregions and motor dysfunction in prodromal and clinical Parkinson’s disease

M. Banwinkler, M. Hoenig, V. Dzialas, T. van Eimeren (Cologne, Germany)

Dysconnectivity of the Parafascicular Nucleus in Parkinson’s Disease

L. Chen, T. Wu (Beijing, China)

Dysconnectivity Profiles of Raphe Nuclei in Parkinson’s Disease: From Prodromal to Advanced Stage

W. Junling, S. Junyan, Z. Dongling, C. Lili, W. Tao (Beijing, China)

Early neurotransmitters changes in Parkinson’s disease with REM sleep behaviour disorder

D. Urso, B. Tafuri, S. Nigro, V. Gnoni, I. Rosenzweig, K. Ray Chaudhuri, G. Logroscino (Tricase, Italy)

Early-phase 18F-FP-CIT PET images: a promising imaging biomarker for predicting early dementia conversion in Parkinson’s disease

SJ. Chung, MY. Chun, T. Lee, SH. Kim, HS. Lee, YJ. Kim, PH. Lee, Y. Jeong, YH. Sohn (Yongin-si, Republic of Korea)

Effects of intermittent theta burst stimulation over primary motor cortex on functional connectivity in Parkinson’s disease patients

G. Kotsoev, E. Fedotova, E. Kremneva, I. Bakulin, A. Poydasheva, N. Suponeva (Moscow, Russian Federation)

Evidence of Central Autonomic Network dysfunction in orthostatic hypotension of Parkinson’s disease

L. Xavier, E. Dayan, N. Browner, M. Sklerov (Carrboro, USA)

Examining the Correlation Between Multi-Spectral Diffusion Weighted Imaging Quantitative Maps and Unified Parkinson’s Disease Rating Scale Scores

I. Shelley, I. Ailes, M. Syed, K. Shivok, J. Miao, L. Krisa, F. Mohamed, R. Sergott, T. Liang, A. Sharan, M. Kogan, C. Wu, M. Alizadeh (Philadelphia, USA)

Explainable deep learning based detection of Parkinson’s changes in MRI brain scans

M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes

S. Roytman, Y. Ota, T. Brown, P. Scott, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

Functional circuit abnormalities in Levodopa-induced dyskinesia in Parkinson’s disease: A systematic review

B. Thomsen, M. Vinding, D. Meder, L. Marner, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

Functional connectivity fingerprints in Parkinson’s disease patients with hallucinations

S. Stampacchia, F. Bernasconi, J. Potheegadoo, J. Pagonabarraga, J. Kulisevsky, D. van Deville, E. Amico, O. Blanke (Geneve, Switzerland)

Functional network correlates of APOE ε4 allele in Parkinson’s disease

K. Schindlbeck, A. Vo, P. Mattis, N. Nguyen, D. Eidelberg (Munich, Germany)

Genetic polymorphisms associated with nigrostriatal dopaminergic depletion as measured with [I123]-FP-CIT SPECT in Parkinson’s disease

S. Castro Labrador, MA. Labrador Espinosa, J. Silva Rodríguez, D. García Solís, P. Mir, MJ. Grothe (Seville, Spain)

Gray matter volume changes in occipital and temporal visual brain region are associated with freezing of gait in Parkinson’s

YX. Li, ZL. Luo, XL. Yang (Kunming, China)

Habenula Volume in Mood Disorders in Parkinson’s Disease

B. Samanci, Y. Temel, M. Kuijf, S. Tan, S. Michielse (Maastricht, Netherlands)

How helpful is the Swallow tail sign in Parkinson’s disease?

M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi, Kuwait)

Imaging the noradrenergic system in Parkinson’s disease: A [11C]Yohimbine PET and neuromelanin MRI study

C. Laurencin, S. Lancelot, M. Huddlestone, S. Brosse, I. Merida, N. Costes, J. Redouté, S. Thobois, P. Boulinguez, B. Ballanger (Lyon, France)

Impact of Image-Guided Programming (IGP) in Bilateral STN Deep Brain Stimulation on Programming Time and Setting Outcomes

J. Aldred, T. Zesiewicz, M. Okun, J. Ramirez-Castaneda, L. Verhagen-Mehtman, C. Luca, R. Ramdhani, J. Durphy, Y. Bezchlibnyk, J. Carlson, K. Foote, S. Sani, A. Papanastassiou, J. Jagid, D. Weintraub, J. Pilitsis, B. Reese, L. Chen, R. Jain (Spokane, USA)

Impaired structural connectivity in Parkinson’s disease with probable RBD

J. Oltra, I. Roura, A. Campabadal, C. Uribe, J. Pardo, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)

In vivo positive amyloid PET in a patient with PDD, always reliable?

S. Enriquez, D. Samaniego, C. Lorenzo-Bosquet, E. Martinez-Saez, A. Garcia-Serra, B. Garcé, S. Belmonte, J. Hernández-Vara (Barcelona, Spain)

Increased free water in the putamen in idiopathic REM sleep behaviour disorder

D. Zhang, L. Zhou, J. Liu, T. Wu (Beijing, China)

Insular dopamine deficits in prodromal α-synucleinopathies

A. Galli, A. Pilotto, C. Zatti, F. Placidi, F. Izzi, E. Premi, A. Rizzardi, M. Catania, A. Lupini, L. Purin, M. Pasolini, N. Mercuri, A. Chiaravalloti, M. Fernandes, C. Calvello, B. Paghera, D. Berg, A. Padovani, C. Liguori (Brescia, Italy)

Integrative brain states facilitate the expression of Parkinson’s tremor

MF. Dirkx, M. Shine, RC. Helmich (Nijmegen, Netherlands)

Is working memory training success in Parkinson’s disease determined by cortical thickness and white matter lesions?

K. Giehl, H. Theis, A. Ophey, J. Hammes, P. Reker, C. Eggers, E. Kalbe, T. van Eimeren (Cologne, Germany)

Longitudinal brain volume decline in PD with RBD and olfactory dysfunction

K. Kawabata, E. Bagarinao, K. Seppi, W. Poewe (Innsbruck, Austria)

Longitudinal changes in brain networks associated with clinical symptoms in idiopathic rapid eye movement sleep behavior disorder

N. Wakasugi, T. Takamura, M. Abe, Y. Mukai, N. Nishikawa, T. Hatano, Y. Shimo, K. Ikenaka, H. Kadotani, Y. Sumi, N. Sawamoto, H. Watanabe, H. Mochizuki, N. Hattori, M. Katsuno, Y. Takahashi, R. Takahashi, T. Hanakawa (Tokyo, Japan)

Machine learning diagnosis of parkinsonian syndromes: network approach with two different sites

M. Perovnik, T. Rus, A. Vo, N. Nguyen, P. Tomše, J. Jamšek, C. Tang, M. Trošt, D. Eidelberg (Ljubljana, Slovenia)

Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)

Marked reduction of energy supply due to levodopa treatment in patients with Parkinson’s disease and healthy controls

J. Prasuhn, T. Schiefen, T. Grüber, J. Hekel, J. Uter, J. Steinhardt, B. Wilms, N. Brüggemann (Lübeck, Germany)

Metabolic connectivity assessed by dynamic FDG-fPET acquisition in Parkinson’s disease: a multimodal fPET and fMRI study

M. Ruppert-Junck, V. Heinecke, K. Steidel, M. Beckersjürgen, D. Librizzi, M. Luster, H. Müller, F. Verburg, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)

Modulation of a subthalamic nucleus related network associated with motor response following Deep Brain Stimulation

P. Unadkat, S. Peng, Y. Ma, V. Dhawan, C. Tang, A. Vo, S. Caminiti, D. Perani, D. Eidelberg (Manhasset, USA)

Monoamine loss and depression in Parkinson’s disease: a PET study

BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan (Beijing, China)

Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography

P. Honhar, S. Tinaz, M. Dias, R. Comley, S. Finnema, R. Carson, D. Scheinost, D. Matuskey (New Haven, USA)

Network analysis of brain perfusion in [11C]UCB-J PET: Parkinson’s related motor pattern (PDRP)

P. Honhar, S. Tinaz, S. Holmes, M. Dias, M. Naganawa, J. Gallezot, S. Henry, R. Comley, N. Nabulsi, Y. Huang, A. Hillmer, R. Carson, S. Finnema, D. Matuskey (New Haven, USA)

Network attack tolerance: A resilience proxy for Parkinson’s disease?

A. Asendorf, A. Temizyürek, M. Banwinkler, V. Dzialas, THE. Parkinson-Progression-Marker-Initiative, T. van Eimeren, M. Hoenig (Cologne, Germany)

Neurite Orientation Dispersion and Density Imaging and Diffusion Kurtosis Imaging in Brainstem Nuclei for Subtypes of Parkinson’s Disease

N. Joshi, I. Aisles, I. Shelley, K. Talekar, M. Alizadeh (Philadelphia, USA)

Neurogenic Orthostatic Hypotension in Parkinson’s Disease: Is there a role for Locus Coeruleus Magnetic Resonance Imaging?

G. Palermo, G. Bellini, A. Galgani, F. Lombardo, N. Martini, R. Morganti, D. Paoli, S. de Cori, FS. Giorgi, R. Ceravolo (Pisa, Italy)

Neuroimaging analysis of postural instability in Progressive Supranuclear Palsy: a Voxel‐based morphometry approach

C. Calomino, MG. Bianco, J. Buonocore, F. Aracri, M. de Maria, A. Sarica, A. Quattrone (Catanzaro, Italy)

Neuroimaging correlates of postural instability in motor subtypes of Parkinson’s disease

A. Quattrone, C. Calomino, A. Sarica, M. Caligiuri, M. Bianco, B. Vescio, J. Buonocore, M. Vaccaro, A. Quattrone (Catanzaro, Italy)

Neuromelanin related 7T MRI of the locus coeruleus differs between Parkinson’s disease and controls

A. Wolters, M. Heijmans, N. Priovoulos, H. Jacobs, A. Postma, Y. Temel, M. Kuijf, S. Michielse (Maastricht, Netherlands)

Non-tremor motor dysfunction in Parkinson’s disease is associated with decreased [18F]FMPEP-d2 binding

R. Ajalin, H. Al-Abdulrasul, J. Tuisku, J. Hirvonen, S. Lahdenpohja, J. Rinne, A. Brück (Espoo, Finland)

Patterns of Parkinson disease mitochondrial brain function indexed by 31P magnetic resonance spectroscopy

F. Lopez, C. Hess, A. Ray, R. O'Connell, A. O'Shea, L. Kenney, A. Ratajska, G. Alexander, A. Woods, M. Okun, D. Bowers (Gainesville, USA)

People with Parkinson’s Disease present compensatory cortical activity patterns during split-belt treadmill walking, regardless of leg or disease side dominance.

F. Hulzinga, P. Pelicioni, N. D'Cruz, V. de Rond, P. Ginis, M. Gilat, A. Nieuwboer (Heverlee

PET visualization of α-synuclein pathologies in humans using [18F]C05-05

H. Endo, K. Matsuoka, Y. Kataoka, K. Tagai, K. Hirata, N. Kokubo, A. Orihara, M. Oya, H. Matsumoto, S. Kurose, M. Ichihashi, A. Oyama, S. Kitamura, H. Zhang, C. Seki, K. Takahata, T. Tokuda, M. Ono, Y. Takado, H. Shinotoh, A. Sugiyama, T. Hatano, H. Shimada, K. Kawamura, MR. Zhang, M. Higuchi (Chiba, Japan)

Progression of striatocortical dysfunction in Parkinson’s disease: a longitudinal combined PET and fMRI study

K. Steidel, M. Ruppert-Junck, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers, D. Pedrosa (Marburg, Germany)

Progressive cortical cerebrovascular reactivity reduction occurs in Parkinson’s disease: a longitudinal study

LR. Jin (Shanghai, China)

Radiological markers of CSF α-synuclein aggregation in Parkinson’s disease patients

A. Droby, A. Yoffe-Vasiliev, K. Fraser, O. Mabrouk, B. Cohen, N. Omer, A. Bar Shira, M. Gana-Weisz, O. Goldstein, R. Alcalay, A. Orr-Urtreger, J. Shirvan, J. Cedarbaum, N. Giladi, A. Mirelman, A. Thaler (Tel-Aviv, Israel)

Relevance of amyloid deposition for REM sleep behavior disorder in Parkinson’s disease

J. Pineda-Pardo, M. López-Aguirre, G. Pagano, V. Gnoni, K. Ray Chaudhuri, G. Logroscino, D. Urso (Madrid, Spain)

Role of the direct subthalamo-cerebellar tract in memory and learning: Implications for the pathophysiology of late-stage Parkinson’s Disease

V. Radhakrishnan, C. Gallea, S. Krishnan, B. Thomas, C. Kesavadas, A. Kishore (Trivandrum, India)

Structural MRI and tremor analysis in the differential diagnosis of rest tremor

F. Aracri, M. Bianco, C. Calomino, M. de Maria, B. Vescio, J. Buonocore, A. Sarica, A. Quattrone (Catanzaro, Italy)

Subthalamic stimulation reshapes the reliable inherent brain state in Parkinson’s disease

C. Chu, N. He, Z. Zeng, Y. Zhang, X. Wang, Z. Zhang, J. Wang, Y. Wang, Z. Jiang, Y. Lu, B. Sun, F. Yan, D. Li, C. Zhang, C. Liu (Tianjin, China)

T1 MRI reveals differential hippocampal atrophy in Lewy body disorders with and without Alzheimer’s copathology

J. Cohen, J. Phillips, S. Das, E. Rhodes, K. Cousins, P. Yushkevich, D. Wolk, D. Weintraub, D. Irwin, C. Mcmillan (Philadelphia, USA)

The Critical Path for Parkinson’s Consortium approach to developing consensus recommendations for neuroimaging biomarkers appropriate for use in Parkinson’s disease drug development

M. Muller, R. Comley, J. Eberling, H. Kazmi, T. Kustermann, P. Maguire, K. Marek, C. Mcginnity, M. Minchik, C. Parker, L. Passamonti, O. Rousset, D. Russell, C. Salinas, J. Seibyl, S. Sivakumaran, J. Stoessl, A. Strafella, D. Tosun-Turgut, Y. Wang, D. Stephenson, G. Pagano (Tucson, USA)

The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson’s disease

W. Li, R. Li, J. Lu (Beijing, China)

The High Prevalence of Developmental Vascular Anomalies in Parkinson’s Disease using USPIO-based MICRO MRI

S. Sharma, S. Buch, D. Reese, T. Wade, G. Prado Miranda, M. Haacke, C. Tzoulis, M. Jog (London, Canada)

The impact of STN-DBS on brain metabolic activity during dynamic obstacle avoidance in Parkinson’s disease

I. Hanafi, C. Palmisano, G. Marotta, J. Delvecchio Delvecchio, G. Pezzoli, J. Volkmann, A. Buck, N. Pozzi, I. Isaias (Würzburg, Germany)

Visual networks connectivity in subjects with Parkinson’s disease and visual disturbances using resting state fMRI

O. Shoraka, M. Syed, I. Shelley, K. Shivock, TW. Liang, RC. Sergott, I. Fayed, A. Sharan, M. Alizadeh (Philadelphia, USA)

Visuo-spatial processing is linked to cortical glutamate dynamics in Parkinson’s disease – a 7 Tesla functional MRS study

A. Ophey, E. Farrher, N. Pagel, A. Seger, C. Doppler, N. Shah, E. Kalbe, G. Fink, M. Sommerauer (Cologne, Germany)

White matter lesion burden is associated with poorer clinical and driving outcomes in mild Parkinson’s disease

E. Uc, V. Magnotta, D. Mcgehee, E. Axelson, M. Mani, J. Dawson, A. Comellas, J. Kline, N. Narayanan, S. Anderson, C. Weber, W. Darling (Iowa City, USA)

White Matter Lesion Characteristics of Patients with Multiple Sclerosis and Parkinsonism

Y. Shi, S. Gadani, K. Mills (Baltimore, USA)

White matter lesions and motor symptoms in Parkinson’s disease

S. Jost, A. Sauerbier, A. Rizos, M. Picillo, D. van Wamelen, V. Stopic, JN. Petry-Schmelzer, M. Schönfeld, N. Abdullayev, K. Ashkan, K. Rukavina, J. Jarosz, M. Sommerauer, M. Qamar, R. Cury, E. Fonoff, M. Dos Santos-Ghilardi, A. Othman, M. Muthuraman, GR. Fink, A. Antonini, L. Timmermann, P. Martinez-Martin, A. Fasano, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)